Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON GSK PHARMA BIOCON /
GSK PHARMA
 
P/E (TTM) x 36.9 57.5 64.1% View Chart
P/BV x 4.1 8.5 48.7% View Chart
Dividend Yield % 0.2 6.7 2.6%  

Financials

 BIOCON    GSK PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-22
GSK PHARMA
Mar-22
BIOCON /
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs4241,917 22.1%   
Low Rs3151,400 22.5%   
Sales per share (Unadj.) Rs68.2193.5 35.2%  
Earnings per share (Unadj.) Rs8.222.5 36.3%  
Cash flow per share (Unadj.) Rs14.926.5 56.3%  
Dividends per share (Unadj.) Rs0.5090.00 0.6%  
Avg Dividend yield %0.15.4 2.5%  
Book value per share (Unadj.) Rs68.5157.2 43.6%  
Shares outstanding (eoy) m1,200.60169.41 708.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.48.6 63.2%   
Avg P/E ratio x45.373.8 61.4%  
P/CF ratio (eoy) x24.762.6 39.5%  
Price / Book Value ratio x5.410.6 51.1%  
Dividend payout %6.1400.4 1.5%   
Avg Mkt Cap Rs m443,622280,960 157.9%   
No. of employees `000NANA-   
Total wages/salary Rs m18,8016,102 308.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m81,84032,780 249.7%  
Other income Rs m6,891758 909.4%   
Total revenues Rs m88,73133,538 264.6%   
Gross profit Rs m13,8277,735 178.8%  
Depreciation Rs m8,142682 1,194.1%   
Interest Rs m67620 3,386.8%   
Profit before tax Rs m11,9007,790 152.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,1153,983 53.1%   
Profit after tax Rs m9,7853,808 257.0%  
Gross profit margin %16.923.6 71.6%  
Effective tax rate %17.851.1 34.8%   
Net profit margin %12.011.6 102.9%  
BALANCE SHEET DATA
Current assets Rs m83,82337,080 226.1%   
Current liabilities Rs m38,28016,984 225.4%   
Net working cap to sales %55.661.3 90.8%  
Current ratio x2.22.2 100.3%  
Inventory Days Days10191 110.5%  
Debtors Days Days92229 40.2%  
Net fixed assets Rs m117,1848,121 1,443.0%   
Share capital Rs m6,0031,694 354.4%   
"Free" reserves Rs m76,28124,936 305.9%   
Net worth Rs m82,28426,630 309.0%   
Long term debt Rs m39,9850-   
Total assets Rs m201,00745,201 444.7%  
Interest coverage x18.6391.3 4.8%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.40.7 56.1%   
Return on assets %5.28.5 61.5%  
Return on equity %11.914.3 83.2%  
Return on capital %10.329.3 35.1%  
Exports to sales %00-   
Imports to sales %7.827.0 28.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m6,3608,853 71.8%   
Fx inflow Rs m8,885528 1,683.5%   
Fx outflow Rs m6,3608,853 71.8%   
Net fx Rs m2,525-8,325 -30.3%   
CASH FLOW
From Operations Rs m11,7668,107 145.1%  
From Investments Rs m-16,991-4,055 419.0%  
From Financial Activity Rs m2,421-5,242 -46.2%  
Net Cashflow Rs m-2,433-1,190 204.5%  

Share Holding

Indian Promoters % 39.7 0.0 -  
Foreign collaborators % 21.0 75.0 28.0%  
Indian inst/Mut Fund % 23.6 12.7 185.3%  
FIIs % 15.8 2.2 727.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 25.0 157.4%  
Shareholders   369,816 116,651 317.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Biocon vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs GSK Pharma Share Price Performance

Period Biocon GSK Pharma S&P BSE HEALTHCARE
1-Day -0.63% 0.94% -0.10%
1-Month 5.56% -2.54% -1.99%
1-Year -22.75% -21.20% -5.62%
3-Year CAGR -0.26% -7.15% 20.96%
5-Year CAGR -11.19% -11.37% 11.47%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 6.1%.

GSK Pharma paid Rs 90.0, and its dividend payout ratio stood at 400.4%.

You may visit here to review the dividend history of Biocon, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.